The use of liposomes functionalized with the NFL-TBS.40–63 peptide as a targeting agent to cross the in vitro blood–brain barrier and target glioblastoma cells
Adélie Mellinger, Larissa J. Lubitz, Claire Gazaille, Gero Leneweit, Guillaume Bastiat, Claire Lépinoux-Chambaud, Joël Eyer
Topics & Concepts
LiposomeBlood–brain barrierIn vitroPeptideDrug deliveryCell-penetrating peptideCancer researchGlioblastomaCytotoxicityBrain tumorChemistryPharmacologyMedicinePathologyBiochemistryCentral nervous systemInternal medicineOrganic chemistryRNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryBarrier Structure and Function Studies